Cite

HARVARD Citation

    Petelin, L. et al. (2018). Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review. Genetics in medicine. pp. 1145-1156. [Online]. 
  
Back to record